Corporate America faces a demanding earnings season, with S&P 500 profits expected to jump more than 30% even as the Fed remains cautious about its next move. Meanwhile, multibillion-dollar acquisitions are keeping dealmaking alive, while fresh market turmoil overseas highlights the risks lurking beneath the surface.
The 401(ai) Reveal (Sponsored)
After nearly 60 years on Wall Street, Marc Chaikin just finished a new project for Americans who feel behind on retirement.
He calls it the 401(ai).
See why.
*This ad is sent on behalf of Chaikin Analytics, 201 King Of Prussia Rd., Suite 650, Radnor, PA 19087. If you would like to optout from receiving offers from Chaikin Analytics please click here.
Futures at a Glance📈
Futures are edging higher as Wall Street finds some footing after a volatile week for tech. Easing Fed rate-hike fears are helping steady sentiment, though concerns over AI spending and elevated oil prices remain. Traders are also watching fresh industrial production data and another round of bank earnings.
Want to make sure you never miss a pre-market alert?
Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone before the bell.
Email’s great. Texts are faster.
You’ll be first in line when the market starts moving.
What to Watch
Earnings (Premarket):
· Travelers Companies, Inc. [TRV]
· Truist Financial Corporation [TFC]
· M&T Bank Corporation [MTB]
· Citizens Financial Group, Inc. [CFG]
· Regions Financial Corporation [RF]
Earnings (Time Not Supplied):
· HDFC Bank Limited [HDB]
· ICICI Bank Limited [IBN]
· BancFirst Corporation [BANF]
· Republic Bancorp, Inc. [RBCAA]
· MetroCity Bankshares, Inc. [MCBS]
Economic Reports:
· Import prices (September): 8:30 am
· Industrial production (September): 9:15 am
· Capacity utilization (September): 9:15 am
· Monthly Treasury balance (September): 2:00 pm
Market Pulse
Fed Chair Kevin Warsh offered little guidance on the next rate decision as he emphasized U.S. economic resilience while acknowledging investment-driven inflation pressures and global energy shocks.
Third-quarter earnings face a demanding hurdle across the S&P 500, with analysts projecting 30.6% profit growth, even as gains outside the biggest technology companies remain far more modest.
Technology & Industry
Schneider Electric raised its 2026 outlook for the second time as data-center demand drove record quarterly sales, lifting its organic revenue growth target to 12%–14%.
Indian IT firm Tech Mahindra reported $1.02 billion in new deals as quarterly revenue exceeded analyst expectations, suggesting stronger demand for large outsourcing contracts.
Healthcare & Biotech
Revolution Medicines is preparing to launch its pancreatic cancer drug independently in Europe after receiving a positive regulatory committee opinion, challenging the traditional biotech partnership model.
AstraZeneca agreed to pay insitro $40 million upfront under a drug-discovery partnership involving milestone payments worth up to $1.5 billion, targeting difficult-to-treat liver and heart diseases.
Elite Picks (Sponsored)
This report focuses on a narrow group of stocks identified through a detailed screening process.
Analysts apply a combination of metrics to narrow down potential opportunities.
Past selections have shown strong momentum, but no outcomes are guaranteed.
The newest edition is now open for access.
Get the report now.
*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.
Finance & Deals
GTCR and Elliott agreed to acquire CCC Intelligent Solutions for $6.1 billion in a take-private deal for insurance software, offering shareholders $7.75 per share.
Labcorp is buying parts of OPKO Health's BioReference business for up to $872 million through a deal expanding laboratory testing, including prostate cancer diagnostics.
Capital & Energy
Indonesia's stock market plunged 11% after MSCI questioned its emerging-market status as a potential downgrade threatened investments, intensifying concerns about market access and capital outflows.
Venture Global signed deals with GE Vernova and Baker Hughes to develop up to 16 power units, expanding dedicated generation capacity for energy-intensive LNG operations.
Would you rather have access to full Level 2 order-book depth, or just the best bid and ask (Level 1)?
Movers and Shakers
CoreWeave [CRWV]: Premarket Move: −4%
CoreWeave slipped as mounting debt concerns continued weighing on the AI infrastructure company. Yields on some of its bonds surged above 16%, signaling growing investor anxiety over its roughly $50 billion debt burden. Despite management pointing to a $100 billion revenue backlog, traders remain concerned that rising borrowing costs could undermine the economics of its massive data center expansion.
Tesla [TSLA]: Premarket Move: +5%
Tesla jumped after unveiling its long-awaited next-generation Roadster, featuring SpaceX-designed rocket thrusters. During Thursday's demonstration, the prototype drove upside down, performed midair maneuvers, and accelerated from 0 to 60 mph in under one second. Production is now targeted for 2028, and while the specialty vehicle is unlikely to meaningfully impact earnings, the dramatic reveal reignited enthusiasm around Tesla's engineering capabilities.
Regencell Bioscience [RGC]: Premarket Move: +8%
Regencell Bioscience extended its rally after Thursday's sharp double-digit share advance, when the stock gained more than 17% amid elevated trading volume. The speculative biotech has attracted renewed momentum despite reporting an $11.7 million annual net loss and generating no revenue. With no major new clinical announcement driving the move, the continued gains appear tied more to speculative buying than a fundamental change in the company's outlook.
Grid Wasn’t Ready (Sponsored)
One chatbot question, and a server warehouse somewhere in America draws on the grid. Scale that across hundreds of millions of people daily.
Name the stock by text.
Data centers used 4.4% of U.S. electricity in 2023, per Lawrence Berkeley National Laboratory. Its 2028 projection: up to 12%.
Send the ticker and story.
Close to a tripling in five years, on a grid that was not built for it. One company sits right where that power comes from.
Which energy company is it?
*This ad is sent on behalf of Guardian Financial Publishing LLC, doing business as Stable Financial Publishing, 1013 Centre Road Suite 403-D, Wilmington, DE 19805. Nothing here is investment, financial, legal, or tax advice, and it is not a recommendation or solicitation to buy or sell any security. Investing involves substantial risk, including loss of principal; past performance does not guarantee future results. Data-center electricity figures are third-party estimates and projections, and AI IPO timing reflects investor expectations, not company guidance. References to OpenAI, Anthropic and Lawrence Berkeley National Laboratory are for informational purposes only; Stable Financial Publishing is not affiliated with, endorsed by, or sponsored by OpenAI, Anthropic or Lawrence Berkeley National Laboratory. Stable Financial Publishing, its owners, employees and contributors may hold positions in securities mentioned and may trade them at any time. Privacy: https://guardian.pub/privacy-policy/ · Terms: https://guardian.pub/terms-of-service/
Everything Else
🔬 The Magnificent Seven drove years of gains but seven new contenders are already quietly building the fundamentals analysts watch before a new leadership cycle begins.
💻 CCC Intelligent Solutions agreed to a $6.1 billion buyout by private equity firms GTCR and Elliott, offering shareholders $7.75 per share in cash.
🥇 Gold Fields pursued a $27 billion takeover of Australia's Northern Star Resources, although resistance from the target and shareholder concerns have complicated negotiations.
💊 Eli Lilly rallied following an analyst upgrade, gaining more than 3% Thursday as investors shifted toward healthcare stocks.
🛒 Walmart climbed after a bullish upgrade from Deutsche Bank, outperforming as investors favored defensive consumer businesses.
💻 Tech Mahindra jumped on strong contract wins, with new deals reaching $1.02 billion, up 25.4% year over year, prompting a Morgan Stanley rating upgrade.
You Read This Far. Here's Where the Real Work Lives.
We run three live portfolios on Autopilot, and everything about them is public: every position, every allocation, every trade, visible the moment it happens.
We keep our own money in each one, because analysis you won't fund yourself is just content.
THE UNBREAKABLE STACK
Our growth book: durable software and cybersecurity names built to compound quietly for years.
THE HORMUZ PREMIUM
Our energy thesis: built for how that sector actually pays, over quarters, not headlines.
THE ELON INDEX
Our conviction bet on the Musk universe: Tesla, and the companies orbiting his ventures, energy, AI, infrastructure. High-beta by design, for investors who want direct exposure to the trade rather than watching it from the sidelines.
And here's the part that makes it effortless: Autopilot does the trading for you. Connect the brokerage you already use (Robinhood, Schwab, Fidelity, and more) and every move we make gets mirrored in your own account automatically.
Your money never leaves your brokerage. It stays in your account, under your control, and you can override any trade or disconnect anytime. Autopilot even rebalances automatically when allocations drift, and you get a notification every time something happens.
No watching tickers. No timing entries. No fat-finger mistakes at market open. You pick the portfolio, we do the work, your account follows along.
Pick the one that fits your risk level, or run all three:
Live portfolios, real positions, our own capital at stake. Your funds stay in your own brokerage account. Past performance doesn't guarantee future results.
That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.
Best Regards,
— Adam Garcia
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
